Liom Health AG
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Liom Health AG - overview
Established
2017
Location
Pfaffikon, -, Switzerland
Primary Industry
Medical Devices & Equipment
About
Based in Pfäffikon, Switzerland, and founded in 2017 by CEO Leo Grünstein, Spiden AG, d. b. a. Liom operates as a healthcare technology company that develops a technology platform to analyze biomarkers and drugs in real time through spectroscopic measurements of body fluids, especially blood.
In December 2024, Liom raised USD 25 million in series A funding from unspecified investors. Liom provides a non-invasive glucose monitoring device integrated with various health metrics. This wearable technology provides continuous glucose measurements without the need for skin penetration, allowing for real-time tracking of glucose levels. The device also monitors other health aspects such as metabolic responses, activity levels, cardiovascular health, and sleep quality.
It delivers predictive alerts and insights into meal optimization, fitness tracking, and mental well-being. In December 2025, Liom Health AG raised CHF 13 million in series A funding from Red Bull Ventures. The company plans to utilize the December 2025 funding to support miniaturization of proprietary Raman spectroscopy platform and transition to product development and commercialization.
Current Investors
b2venture, Geberit International AG, Ornament Health AG
Primary Industry
Medical Devices & Equipment
Sub Industries
Monitoring Equipment
Website
www.liom.com/
Verticals
HealthTech, Wearables & Quantified Self
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.